Guardant Health, Inc.

GH · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

–

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders4.0%

Institutions100.9%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$982.02M	$739.02M	$563.95M	$449.54M	$373.65M	$286.73M	$214.38M	$90.64M
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$349.01M	–	–	–	–	–	–	–
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$437.25M	-$443.59M	-$564.73M	-$544.38M	-$411.00M	-$254.95M	-$82.37M	-$92.94M
Operating income as a percentage of revenue.	-44.5%	-60.0%	-100.1%	-121.1%	-110.0%	-88.9%	-38.4%	-102.5%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$416.28M	-$436.37M	$0	$0	$20.90M	$7.50M	$7.80M	-$85.06M
Net income divided by the number of shares outstanding — profit attributable to each share.	$-3.32	$-3.56	$-4.28	$-6.41	$-4.00	$-2.60	$-0.84	$-2.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$-3.32	$-3.56	$-4.28	$-6.41	$-4.00	–	–	–

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$378.20M	$525.54M	$1.13B	$141.65M	$492.20M	$832.98M	$143.23M	$140.54M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$2.01B	$1.49B	$1.79B	$1.61B	$2.20B	$2.27B	$962.53M	$587.40M
Everything the company owes — debt, unpaid bills, and other obligations.	$2.11B	$1.63B	$1.63B	$1.55B	$1.56B	$916.19M	$114.54M	$62.45M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	-$99.31M	-$139.65M	$158.68M	$60.18M	$645.00M	$1.30B	$798.39M	$483.15M

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$184.76M	-$239.86M	-$324.98M	-$309.46M	-$209.02M	-$103.93M	-$47.13M	-$72.19M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$48.31M	$35.09M	$20.49M	$77.46M	$75.03M	$36.17M	$18.72M	$20.20M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$233.07M	-$274.94M	-$345.46M	-$386.92M	-$284.05M	-$140.10M	-$65.85M	-$92.39M

	You	Peer avg
P/E	–	22.3
Revenue Growth	+44.3%	+7.5%
ROE	–	12.3%

Guardant Health, Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison